Medial EarlySign ' s clinical validation trial shows promise for detecting colorectal cancer

A new clinical validation study, published in the Journal of Clinical Oncology CCI, found that Medial EarlySign ’s artificial intelligence tool flagged about 8 percent of patients in a large trial group that were later diagnosed with cancer or precancerous lesions. 
Source: mobihealthnews - Category: Information Technology Source Type: news